Type 2 Diabetes

ACP Defends Higher Blood Glucose Targets for Type 2 Diabetes

ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c ...

Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes

An increasing number of studies support the use of continuous glucose monitoring in adult patients with T2D, and the observed benefits are likely to extend ...

Ask the Experts: Dr Goyal on SGLT2 Inhibitors

Dr Goyal from NYU Langone Health in New York City talks about SGLT2 inhibitors in the treatment of type 2 diabetes.

Addressing Psychological Insulin Resistance in Patients With Diabetes

Learn about strategies to reduce a patient's reluctance to initiate insulin therapy, a phenomenon called psychological insulin resistance.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D

Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes.

Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?

Updated meta-analysis confirms the association between antidepressant drug (AD) use and incident diabetes. Future studies should be aimed at evaluating the effect of single AD ...

Video

Latest Headlines

ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care

ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care

The ADA published its 2019 Standards of Medical Care in Diabetes, an evidence-based document intended to provide clinicians, patients, and other stakeholders in the diabetes treatment landscape with up-to-date recommendations.

SGLT2 Inhibitors and Urinary Tract Infections: What's the Link?

SGLT2 Inhibitors and Urinary Tract Infections: What's the Link?

For this study, the authors identified randomized controlled trials (RCTs) that compared SGLT2 inhibitors with placebo, no treatment, or another antidiabetic agent and reported on UTI outcome.

Metabolic Syndrome Highly Prevalent in Patients With Plaque Psoriasis

Metabolic Syndrome Highly Prevalent in Patients With Plaque Psoriasis

Metabolic syndrome and psoriatic arthritis were highly prevalent comorbidities in patients with plaque psoriasis.

T2D Linked to Decline in Verbal Memory, Fluency in Older Adults

T2D Linked to Decline in Verbal Memory, Fluency in Older Adults

Type 2 diabetes is associated with declines in verbal memory and fluency among older community-dwelling adults.

Low-Risk Patients With T2D May Be Self-Testing Blood Glucose Too Often

Low-Risk Patients With T2D May Be Self-Testing Blood Glucose Too Often

Patients with stable type 2 diabetes may be unnecessarily self-monitoring blood glucose levels despite this practice being recognized as a low-value service.

Liraglutide significantly reduces risk for major cardiac events in elderly patients with diabetes

A significant reduction in major cardiac events among elderly patients was seen in the liraglutide treatment group.

A Risk Prediction Tool for Hip Fracture in Type 2 Diabetes

A Risk Prediction Tool for Hip Fracture in Type 2 Diabetes

A hip fracture risk tool for patients with type 2 diabetes performed well in predicting incident hip fractures using readily available variables.

Hypertensive Disorders in Pregnancy, Postpartum BMI Linked to T2D Risk

Hypertensive Disorders in Pregnancy, Postpartum BMI Linked to T2D Risk

Postpartum women with an elevated BMI score and a history of hypertensive disorders during pregnancy have an increased risk of developing type 2 diabetes.

Type 2 Diabetes Linked to Colorectal Cancer Risk in Men

Type 2 Diabetes Linked to Colorectal Cancer Risk in Men

Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only.

Normalized HbA1c Levels Facilitate Improved Neuropathy Outcomes in T2D

Normalized HbA1c Levels Facilitate Improved Neuropathy Outcomes in T2D

Normalized HbA1c levels facilitated improvement in neuropathy and nephropathy in type 2 diabetes of a short duration.

Sign Up for Free e-Newsletters



CME Focus